Zyla Life Sciences Finite-Lived Intangible Assets, Accumulated Amortization
Zyla Life Sciences had Finite-Lived Intangible Assets, Accumulated Amortization of $16.32 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2020-05-14
- 2020-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $16.32M.
- 2019-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $12.82M.
- 2019-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $9.33M.
- 2019-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $5.83M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2020-03-31 | $16.32M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $12.82M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $9.33M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.83M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.33M 10-Q · filed 2019-05-17 |
| 2018-12-31 | $8.17M 10-K · filed 2020-03-26 |
| 2018-09-30 | $7.70M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $7.25M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $6.86M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $6.27M 10-K · filed 2019-03-29 |
| 2017-09-30 | $5.70M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.11M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.47M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.95M 10-K · filed 2018-03-16 |
| 2016-09-30 | $3.47M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $2.96M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $2.47M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.96M 10-K · filed 2017-03-13 |
| 2015-09-30 | $1.47M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $963.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $378.00K 10-Q · filed 2015-05-08 |